Retrogenix provides a fast, accurate and effective solution for primary receptor identification and specificity screening of antibodies, protein ligands, CAR T cells, viruses and small molecules. Physiologically-relevant targets are identified by screening for interactions against the most comprehensive set of plasma membrane proteins available in the context of human cells. This specific sensitive technology is widely used by major global pharmaceutical companies to advance drug discovery and development, predominantly in biologics research.